Follow
Mikhail Osipovitch
Mikhail Osipovitch
Intomics A/S
Verified email at intomics.com
Title
Cited by
Cited by
Year
Human iPSC glial mouse chimeras reveal glial contributions to schizophrenia
MS Windrem, M Osipovitch, Z Liu, J Bates, D Chandler-Militello, L Zou, ...
Cell stem cell 21 (2), 195-208. e6, 2017
2442017
Human glia can both induce and rescue aspects of disease phenotype in Huntington disease
A Benraiss, S Wang, S Herrlinger, X Li, D Chandler-Militello, J Mauceri, ...
Nature communications 7 (1), 11758, 2016
1832016
Human ESC-derived chimeric mouse models of Huntington’s disease reveal cell-intrinsic defects in glial progenitor cell differentiation
M Osipovitch, AA Martinez, JN Mariani, A Cornwell, S Dhaliwal, L Zou, ...
Cell stem cell 24 (1), 107-122. e7, 2019
842019
PAR1 inhibition suppresses the self-renewal and growth of A2B5-defined glioma progenitor cells and their derived gliomas in vivo
R Auvergne, C Wu, A Connell, S Au, A Cornwell, M Osipovitch, A Benraiss, ...
Oncogene 35 (29), 3817-3828, 2016
452016
Dysregulated glial differentiation in schizophrenia may be relieved by suppression of SMAD4-and REST-dependent signaling
Z Liu, M Osipovitch, A Benraiss, NPT Huynh, R Foti, J Bates, ...
Cell reports 27 (13), 3832-3843. e6, 2019
402019
Cell-intrinsic glial pathology is conserved across human and murine models of Huntington’s disease
A Benraiss, JN Mariani, M Osipovitch, A Cornwell, MS Windrem, ...
Cell reports 36 (1), 2021
342021
Estimation of protein function using template-based alignment of enzyme active sites
B Hanson, C Westin, M Rosa, A Grier, M Osipovitch, ML MacDonald, ...
BMC bioinformatics 15, 1-11, 2014
182014
Automated protein motif generation in the structure-based protein function prediction tool ProMOL
M Osipovitch, M Lambrecht, C Baker, S Madha, JL Mills, PA Craig, ...
Journal of structural and functional genomics 16, 101-111, 2015
112015
Human glia can both induce and rescue aspects of disease phenotype in Huntington disease. Nat Commun 7: 11758
A Benraiss, S Wang, S Herrlinger, X Li, D Chandler-Militello, J Mauceri, ...
82016
... & Craig
B Hanson, C Westin, M Rosa, A Grier, M Osipovitch, ML MacDonald
P. A, 2014
42014
Comprehensive and unbiased multiparameter high-throughput screening by compaRe finds effective and subtle drug responses in AML models
MC Hajkarim, E Karjalainen, M Osipovitch, K Dimopoulos, SL Gordon, ...
Elife 11, 2022
32022
Methods of treating or inhibiting onset of huntington's disease
SA Goldman, M Osipovitch
US Patent App. 17/254,734, 2022
22022
Methods of treating schizophrenia and other neuropsychiatric disorders
SA Goldman, Z Liu, M Osipovitch
US Patent App. 17/254,008, 2021
22021
compaRe, an ultra-fast and robust suite for multiparametric screening, identifies phenotypic drug responses in acute myeloid leukemia
MC Hajkarim, E Karjalainen, M Osipovitch, K Dimopoulos, SL Gordon, ...
bioRxiv, 2021.01. 08.425880, 2021
12021
Estimation of protein function using template-based alignment of enzyme active sites
PA Craig, HJ Bernstein, T McKay, H Kessler, CW Corwin, PM Boli, ...
12014
Shared patterns of glial transcriptional dysregulation link Huntington’s disease and schizophrenia
NPT Huynh, M Osipovitch, R Foti, J Bates, B Mansky, JC Cano, ...
Brain, awae166, 2024
2024
Cell-Intrinsic Astrocytic Pathology is Conserved Across Both Species and Models of Huntington Disease
A Benraiss, JN Mariani, M Osipovitch, A Cornwell, M Windrem, ...
Available at SSRN 3664180, 2020
2020
miRNA/mRNA NETWORKS IN NEOPLASTIC VERSUS NORMAL GLIAL PRECURSOR CELLS WITHIN HUMAN GLIOMAS
R Auvergne, A Cornwell, M Osipovitch, F Sim, D Chandler-Militello, C Wu, ...
NEURO-ONCOLOGY 18, 44-44, 2016
2016
MS39. O05
H Bernstein, P Craig, A Bangura, A Grier, M Osipovitch, V Kovuri, T McKay, ...
Acta Cryst 70, C598, 2014
2014
Automated Generation of Motif Templates in Protein Function Prediction Software ProMOL
M Osipovitch, HJ Bernstein, PA Craig
The FASEB Journal 27, 811.2-811.2, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–20